Loading...
"Hadrontherapy for life" symposium, caen, march 10/11, 2025-strategy for the future-pancreatic cancer
Habrand, J. L. Haghdoost, S. Harrabi, S. B. Neuzillet, C. Vendrely, V. Light, E. Lubrano, J. Ohno, T. Yamada, S. Wang, Z.
Habrand, J. L.
Haghdoost, S.
Harrabi, S. B.
Neuzillet, C.
Vendrely, V.
Light, E.
Lubrano, J.
Ohno, T.
Yamada, S.
Wang, Z.
Abstract
The symposium"Hadrontherapy for Life," held in Caen, on February 10 and 11, 2025, brought together over 100 international experts of heavy ions particle therapy. Clinical aspects of current indications and future strategies were discussed. Pancreatic cancer that may reach the second cause of cancer mortality in the next decade, was prioritized. Stimulating clinical data accumulated in Japan and more recently in Europe suggest an important role for carbon ion radiotherapy (CIRT) in advanced presentations but also in a preoperative setting, at the price of acceptable toxicity. Biological aspects also plead for combinations of CIRT with bio or immune therapy.
Description
Date
2025
Publisher
Collections
Files
Loading...
Found from Unpaywall
Adobe PDF, 590.96 KB
Keywords
Type
Article
Citation
Habrand JL, Haghdoost S, Harrabi SB, Neuzillet C, Vendrely V, Light E, et al. "Hadrontherapy for life" symposium, caen, March 10/11, 2025-strategy for the future-pancreatic cancer. International Journal of Particle Therapy. 2025 DEC;18.